What do we know about each of the vaccines’ short-term safety?
Paul E. Sax, M.D. Overall, both mRNA vaccines are quite safe — that’s the good news, and it should be the dominant message for our patients. But no vaccine … Read More
Paul E. Sax, M.D. Overall, both mRNA vaccines are quite safe — that’s the good news, and it should be the dominant message for our patients. But no vaccine … Read More
Gorillas at the San Diego Zoo Safari Park have tested positive for SARS-CoV-2. It’s believed that an asymptomatic staff member passed the virus to the gorillas, making it the … Read More
The gut microbiome appears to be altered in patients with COVID-19, finds a study in Gut. Researchers compared blood and stool samples of roughly 100 patients with COVID-19 in Hong … Read More
Three quarters of adults hospitalized with COVID-19 report at least one persistent symptom at 6 months, according to a study in The Lancet. Roughly 1700 COVID-19 patients (median age, 57) … Read More
U.K. health officials now say clinicians should consider using the interleukin-6 (IL-6) inhibitor tocilizumab, with sarilumab as an alternative, for critically ill COVID-19 patients. The recommendation came a day … Read More
Pfizer and BioNTech report that antibodies from people who’ve received the companies’ COVID-19 vaccine can neutralize SARS-CoV-2 carrying the N501Y mutation. N501Y enables SARS-CoV-2’s spike protein to bind more … Read More
Convalescent plasma with high SARS-CoV-2 antibody titers can help prevent progression to severe COVID-19 in older adults with mild disease, according to a New England Journal of Medicine study. Some 160 … Read More
Sensitivity of the BinaxNOW antigen test, compared with polymerase chain reaction testing, was lower when used to test specimens from asymptomatic (35.8%) than from symptomatic (64.2%) persons, but specificity … Read More
During December 21, 2020–January 10, 2021, the administration of 4,041,396 first doses of Moderna COVID-19 vaccine (2,465,411 to females [61%], 1,450,966 to males [36%], and 125,019 to persons whose … Read More
Twenty-one cases of anaphylaxis occurred with the first 1.9 million doses of the Pfizer-BioNTech mRNA COVID-19 vaccine, according to data in MMWR. This equates to a rate of 11.1 cases … Read More